Nivolumab plus ipilimumab in melanoma: Added benefit in certain patients
Nivolumab (trade name: Opdivo) in combination with ipilimumab (trade name: Yervoy) has been approved since May 2016 for adults with advanced melanoma. The German Institute for Quality and Efficiency in Health Care (IQWiG) ...
Oct 6, 2016
0
0